OPPM
BIIB icon

Opus Point Partners Management’s Biogen BIIB Stock Holding History

Opus Point Partners Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-120
Closed -$269K – 66
2014
Q4 		$269K Buy
+120
New +$38.8K 0.27% 55

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Opus Point Partners Management's BIIB Position: Q3 2019 in Review

Opus Point Partners Management held its Biogen (BIIB) position steady in Q3 2019 at 1,123 shares worth $261K. The position accounts for 0.47% of the portfolio, ranked #46.

Opus Point Partners Management first reported a position in BIIB in Q4 2014 and has held it in 19 quarters since. The position peaked at $5.1M in Q3 2015. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

  • Opus Point Partners Management held 1,123 shares of Biogen worth $261K as of Q3 2019.
  • Opus Point Partners Management left its Biogen share count unchanged in Q3 2019.
  • Biogen made up 0.47% of Opus Point Partners Management's portfolio in Q3 2019, its #46 holding.
  • Opus Point Partners Management first reported a position in Biogen in Q4 2014 and has held it in 19 quarters since.
  • Opus Point Partners Management's Biogen position peaked at $5.1M in Q3 2015.
  • 989 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Opus Point Partners Management's 13F filing for Q3 2019, filed 14 Nov 2019.